Mostly Cloudy 65°
Tag:

Moderna

News
COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season
Covid-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season Now that the new COVID-19 vaccine is available in New York, Gov. Kathy Hochul is urging residents to get their updated shots ahead of this year's respiratory virus illness season. Related story - COVID-19: New XEC Strain 'Just Getting Started' Sparks Concern Amid Summer Wave Of US Cases In an announcement this week, Hochul encouraged eligible New Yorkers to get the new Food and Drug Administration-approved vaccine for the 2024-2025 season, offered by Pfizer, Moderna, and Novavax.  According to Hochul, receiving the new vaccine is more pressing as students return to school and …

SHARE

by Ben Crnic
News
FDA Approves Updated COVID-19 Vaccines: Here's When They Will Be Available FDA Approves Updated COVID-19 Vaccines: Here's When They Will Be Available
FDA Approves Updated Covid-19 Vaccines: Here's When They Will Be Available The US Food and Drug Administration has just approved new COVID-19 vaccines.It marks the third time the vaccines from Pfizer and Moderna have been updated to match circulating strains since the original shot. The shots should be available within days, the FDA said in making the announcement Thursday afternoon, Aug. 22. The new vaccines have been updated with a formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID, including hospitalization and death. “Vaccination continues to be the cornerstone of COVID-19 preventi…

SHARE

by Joe Lombardi
News
COVID-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots COVID-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots
Covid-19: New Data Reveals How Many Americans Have Gotten Updated Vaccine Shots New data is shedding light on how many Americans have received a dose of the new COVID-19 booster shot for 2023-24. The updated vaccine has now been available for about a month and a half. More than 1,200 people are dying of COVID each week in the United States  four years after the pandemic started, the CDC says. The Centers for Disease Control and Prevention (CDC) recommended the newest vaccine targeting Omicron subvariants being provided by both Pfizer/BioNTech and Moderna for everyone 6 months of age and older. Another updated vaccine, this one from Novavax, b…

SHARE

by Joe Lombardi
News
COVID-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster COVID-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster
Covid-19: Here's How Many Americans Have Gotten Updated Vaccine Compared To Last Year's Booster More than seven million Americans have received a dose of the newly released COVID-19 booster shot for 2023-24, according to federal authorities. In mid-September, the Centers for Disease Control and Prevention (CDC) recommended the newest vaccine targeting Omicron subvariants being provided by both Pfizer/BioNTech and Moderna for everyone 6 months of age and older. Another updated vaccine, this one from Novavax, became available this month and is recommended for those aged 12 and over.  The rollout of this year's booster was marked early on by some distribution of…

SHARE

by Joe Lombardi
News
COVID-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says COVID-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says
Covid-19: New Vaccine Targeting Omicron Subvariants 'Vital' For NY Residents, Hochul Says New York Gov. Kathy Hochul is urging residents to receive a new, updated COVID-19 vaccine meant to target a mutated variant of the virus.  The new vaccine, approved by the federal Centers for Disease Control and Prevention on Tuesday, Sept. 12, and previously authorized by the federal Food and Drug Administration, is meant to target a subvariant of Omicron called XBB.1.5, Hochul announced on Wednesday, Sept. 13. The vaccine was developed after the FDA decided to target the subvariant, which is closely related to over 90 percent of all circulating COVID viruses, according to the CD…

SHARE

by Ben Crnic
News
COVID-19: FDA Approves Updated Booster Shots Targeting New Variants COVID-19: FDA Approves Updated Booster Shots Targeting New Variants
Covid-19: FDA Approves Updated Booster Shots Targeting New Variants Health officials are one step closer to rolling out updated COVID-19 vaccines just in time for a rise in cases heading into the fall and winter months. The US Food and Drug Administration (FDA) approved new vaccines on Monday, Sept. 11, that are meant to better target currently circulating COVID-19 variants and provide better protection against hospitalization and death, the agency announced. Monday’s move affects vaccines manufactured by Moderna and Pfizer. The updated mRNA vaccines are each approved for people ages 12 and older and are authorized under emergency use for children ages 6 mo…

SHARE

by Michael Mashburn
News
COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA COVID-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA
Covid-19: Vaccine Targeting Omicron Variant Authorized For Young Children By FDA The Food and Drug Administration has authorized the use of updated COVID-19 booster shots targeting the Omicron variant for younger children. The FDA announced the amended emergency use authorization of the bivalent Moderna and Pfizer booster vaccines on Wednesday, Oct. 12. Today, FDA amended the EUA of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. https://t.co/C2Sx5Nkk0R pic.twitter.com/xsPfO2Mek3 — U.S. FDA (@US_FDA) October 12, 2022 The Moderna bivalent booster is autho…

SHARE

by Nicole Valinote
Lifestyle
COVID-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine COVID-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine
Covid-19: Here's Name Of New Booster Targeting Omicron Strain, What To Know, How To Get Vaccine Health experts are recommending the use of updated COVID-19 booster vaccines to protect people from the most prevalent subvariants of the virus currently circulating. The newly-approved boosters are officially named "bivalent vaccines" that target the original strain of COVID-19 and what is now the predominant subvariant of Omicron, BA.5., according to a report from the University of Texas MD Anderson Cancer Center with Dr. David Tweardy, the head of the Department of Infectious Diseases. “The updated COVID-19 boosters are formulated to better protect against the most recently circulating C…

SHARE

by Nicole Valinote
News
COVID-19: New Booster Shots Targeting Omicron Variant Approved By FDA COVID-19: New Booster Shots Targeting Omicron Variant Approved By FDA
Covid-19: New Booster Shots Targeting Omicron Variant Approved By FDA It’s time to roll up your sleeve and get another COVID-19 vaccine. On Wednesday, Aug. 31, the US Food and Drug Administration (FDA) approved updated versions of COVID booster shots made by Pfizer and Moderna that target the highly contagious BA.5 Omicron subvariant. The updated vaccine boosters are designed to give people broad protection against COVID and can help protect against severe illness, hospitalization, and death, the FDA said in a statement. Pfizer’s modified booster was authorized for people ages 12 and older, while Moderna’s shot was approved for those 18 and up. People who…

SHARE

by Michael Mashburn
News
COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel COVID-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel
Covid-19: Vaccines For Kids Under 5 Unanimously Recommended By Expert FDA Panel Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans. The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the vaccines - which are currently only available for Americans 5 years and older - for younger children. All 21 members of the FDA's Vaccines and Related Biological Products Advisory Committee unanimously voted to a…

SHARE

by Zak Failla
News
COVID-19: Updated Vaccine Boosts Protection Against Omicron, Moderna Says COVID-19: Updated Vaccine Boosts Protection Against Omicron, Moderna Says
Covid-19: Updated Vaccine Boosts Protection Against Omicron, Moderna Says Biotechnology company Moderna announced its goal to release an updated booster vaccine this summer after data analysis showed the booster's superior protection against the Omicron variant compared to its original vaccine.  The company said in an announcement on Wednesday, June 8, that data analysis shows that its Omicron-containing bivalent COVID vaccine shows superior neutralizing antibody response against Omicron one month after administration compared to its original vaccine. Moderna said the side effects of the new booster dose are comparable to a booster dose of its original …

SHARE

by Nicole Valinote
News
COVID-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6 COVID-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6
Covid-19: Moderna Seeks Vaccine Authorization For Kids Under Age 6 Moderna says it has submitted a request to the Food and Drug Administration for emergency use authorization of its COVID-19 vaccine for children younger than 6. The company made the announcement on Thursday, April 28, saying it submitted a request to FDA to authorize its vaccine for children from ages 6 months to 6 years old. Moderna's vaccines are currently only authorized for individuals aged 18 and older. "We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," Moderna CEO Stéphane Bancel said. "We believe mRNA-1273…

SHARE

by Nicole Valinote
News
COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans COVID-19: FDA Authorizes Second Booster Shot For This Group Of Americans
Covid-19: FDA Authorizes Second Booster Shot For This Group Of Americans Federal health officials authorized a second booster shot of both the Pfizer and Moderna COVID-19 vaccines for older Americans. On Tuesday, March 29, the Food and Drug Administration (FDA) announced that a second shot has been approved for Americans who are 50 and older once four months have passed since their initial booster. With the FDA's approval, the decision now falls on Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention (CDC), who is expected to sign off on the additional shot as soon as Tuesday afternoon. The second booster shot had already been …

SHARE

by Zak Failla
News
COVID-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days COVID-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days
Covid-19: FDA Expected To Authorize Second Booster Shot For This Age Group Within Days The United States Food & Drug Administration is expected to authorize a second COVID-19 booster shot for some Americans within the next few days, according to multiple reports. CNN reported on Saturday, March 26, that sources said the FDA plans to authorize the additional booster shot for people ages 50 and older in the coming days. An anonymous official told The Washington Post that the authorizations for the additional Moderna and Pfizer booster shots could be announced as soon as Tuesday, March 29. CNN reported that the CDC is expected to give a permissive recommendation following F…

SHARE

by Nicole Valinote
News
COVID-19: Moderna Seeks Approval For Second Booster Shot For All Adults COVID-19: Moderna Seeks Approval For Second Booster Shot For All Adults
Covid-19: Moderna Seeks Approval For Second Booster Shot For All Adults Though the COVID-19 case numbers across the country have either plateaued or are showing improvement, Moderna is now seeking federal approval to administer a second booster shot for adults. Moderna is seeking an amendment of the US Food and Drug Administration’s emergency use authorization for its COVID-19 vaccine to allow for a fourth vaccine to adults 18 and older who have gotten an initial booster. The move by Moderna comes days after Pfizer and BioNTech submitted a similar request for authorization of an additional booster shot, though that vaccine would only be eligible for adults 65 a…

SHARE

by Zak Failla
News
COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed COVID-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed
Covid-19: 'Many Variants Are Coming,' Pfizer CEO Warns, Saying Fourth Shot Will Be Needed Warning that "many variants are coming," the chairman and chief executive officer of Pfizer says a fourth dose of the COVID-19 -- a second booster shot -- will be needed. Appearing on CBS-TV's "Face the Nation" on Sunday, March 13, Dr. Albert Bourla was asked if a COVID booster shot could become recommended each fall - similar to a flu shot. "I think so," Bourla responded. "And I think this is what we are trying now to make." Bourla said Pfizer is trying "very diligently to stay ahead of the virus" because "many variants are coming and Omicron was the first one that was able to evade in a …

SHARE

by Joe Lombardi
News
COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say COVID-19: Johnson & Johnson Pauses Vaccine Production, Reports Say
Covid-19: Johnson & Johnson Pauses Vaccine Production, Reports Say The only Johnson & Johnson facility currently making viable batches of the company's one-dose COVID-19 vaccine has temporarily halted its production, according to a new report. According to The New York Times, Johnson & Johnson has stopped production of its current vaccine, potentially to create a more profitable version aimed at other viruses. With production on hold at its Dutch facility in the city of Leiden, hundreds of millions of doses could be taken out of circulation, though it is unclear how vaccine supplies in the US have been affected. Ayoade Alakija, a co-head of the A…

SHARE

by Zak Failla
News
COVID-19: Moderna Vaccine Gets Full Approval From FDA COVID-19: Moderna Vaccine Gets Full Approval From FDA
Covid-19: Moderna Vaccine Gets Full Approval From FDA Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use. On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago. The move comes after tens of millions of doses of the Moderna vaccine have already been administered across the country. It also represents Moderna’s first FDA-approved product in the US. Officials said the FDA reviewed months of additional follow-up data submitted by Moderna to…

SHARE

by Zak Failla
News
COVID-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready COVID-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready
Covid-19: Pfizer CEO Announces When Vaccine Targeting Omicron Variant Will Be Ready A vaccine targeting the highly transmissible Omicron COVID-19 variant could be on the way from Pfizer. On Monday, Jan. 10, Pfizer CEO Albert Bourla said that booster targeting Omicron will be ready as soon as March, as the company has already begun ramping up production of the doses. “This vaccine will be ready in March,” Bourla told CNBC’s “Squawk Box.” “We (are) already starting manufacturing some of these quantities at risk.” Related story - COVID-19: Fauci Offers New Prediction On When Omicron Wave May Break The vaccine will not exclusively target Omicron, but will also be able to fig…

SHARE

by Zak Failla
News
COVID-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says COVID-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says
Covid-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says The chief executive officer of Moderna has gone on record saying when another round of COVID-19 vaccine booster shots could be required. Moderna CEO Stephane Bancel said this week that due to the efficacy of the vaccine potentially waning over time, a fourth booster could be required before the fall of 2022. Bancel made the proclamation at a Goldman-Sachs-organized healthcare conference, noting that his company is working on a booster shot dedicated to combating the Omicron variant of the virus, which will likely be made available within the next two months. According to recent studies, bo…

SHARE

by Zak Failla
News
COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots
Covid-19: CDC Shortens Waiting Period For Pfizer Booster Shots Americans who received the Pfizer and BioNTech COVID-19 vaccine can now get a booster shot in a shorter timeframe than originally recommended, according to federal health officials who passed a pair of measures to make the vaccine more readily available. The US Centers for Disease Control and Prevention (CDC) announced on Tuesday, Jan. 4 that booster shots should be made available five months after receiving the second dose of the vaccine, down from the original recommendation of at least six months. Those who received the Moderna vaccine must still wait at least six months after their seco…

SHARE

by Zak Failla
News
COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says
Covid-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says A Moderna COVID-19 vaccine booster shot significantly raises the level of antibodies against the new Omicron variant, the company announced on Monday morning, Dec. 20. The currently authorized 50-microgram booster neutralized antibody levels against Omicron approximately 37-fold compared to pre-boost levels and a 100-micrograms dose increased neutralizing antibody levels approximately 83-fold compared to pre-boost levels, the Cambridge, Massachusetts-based company said in a statement. The results are based on laboratory testing. “The dramatic increase in COVID-19 cases from the O…

SHARE

by Joe Lombardi
News
COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab
Covid-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab The Centers for Disease Control and Prevention (CDC) issued new guidance saying that people shouldn’t get the one-dose Johnson & Johnson COVID-19 shot if the Pfizer or Moderna option is available. Citing potentially life-threatening blood clots liked to the J & J jab, the CDC’s Advisory Committee on Immunization Practices (ACIP) met on Thursday, Dec. 16 following an update from the Food and Drug Administration. Federal officials halted the use of the Johnson & Johnson vaccine earlier this year for 10 days in April after six women experienced the blood-clotting problem — the only…

SHARE

by Zak Failla
News
COVID-19: Hochul Announces 'Major Action' To Address Winter Surge COVID-19: Hochul Announces 'Major Action' To Address Winter Surge
Covid-19: Hochul Announces 'Major Action' To Address Winter Surge With a rise in COVID-19 cases expected to continue during the holiday season, New York Gov. Kathy Hochul announced major new measures to address a winter surge. Masks will be required to be worn in all indoor public places unless businesses or venues implement a vaccine requirement, Hochul said. The new business and venue requirements extend to both patrons and staff. The measure is effective Monday, Dec. 13, until Saturday, Jan. 15, when the state will re-evaluate based on current conditions.  "I share New Yorkers’ frustration that we are not past this pandemic, but the winter surge …

SHARE

by Joe Lombardi
News
COVID-19: First Cases Of New Variant Identified In North America COVID-19: First Cases Of New Variant Identified In North America
Covid-19: First Cases Of New Variant Identified In North America The new strain of COVID-19 that has caused worldwide alarm the last week has been detected in North America for the first time. Two cases of the Omicron variant were confirmed in Canada. Both were in Ottawa, Ontario Health Minister Christine Elliott said in a statement released Sunday evening, Nov. 28. The two infected people had traveled from Nigeria and have been isolated, Elliott said. The Omicron variant, whose name comes from the 15th letter of the Greek alphabet, is spreading fast in Europe after the first case was identified by scientists in South Africa on Tuesday, Nov. 9. In…

SHARE

by Joe Lombardi
News
COVID-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says COVID-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says
Covid-19: New Variant's 50 Mutations Make It Different From Original Virus, NIH Director Says Why are scientists so concerned about the new strain of COVID-19? Simply stated, when it comes to Omicron, it's all about the sheer numbers -- as in the number of mutations. "The main thing that has us focused on this and has caused us to be sort of 24-7 on Zoom calls the last four days is that it has so many mutations," Dr. Francis Collins, director of the National Institutes of Health (NIH), said Sunday morning, Nov. 28 on CNN. "Omicron has more than 50 variants that make it different from the original virus, including more than 30 that are in the spike protein." The spike proteins …

SHARE

by Joe Lombardi
News
COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults
Covid-19: FDA Clears Moderna, Pfizer Boosters For All US Adults Federal health officials have given the green light for all Americans to get COVID-19 booster shots for all adults. The Food and Drug Administration (FDA) authorized Moderna and Pfizer COVID-19 booster shots for all adults in the US 18 and older, paving the way for expanding the eligibility of boosters in advance of the holiday season. Previously, the FDA had only authorized booster shots for Americans 65 and older, and those who were at a high risk of contracting COVID-19 due to pre-existing conditions of their job. “Authorizing the use of a single booster dose of either the Moderna or Pf…

SHARE

by Zak Failla
News
COVID-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says COVID-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says
Covid-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says COVID-19 booster shots could soon be made available to all Americans. Dr. Anthony Fauci, one of the country’s foremost authorities on infectious diseases, said this week that Pfizer and Moderna boosters could be coming for all, not just certain groups that are currently eligible. Currently, Americans who are over the age of 65, those who are immunocompromised, and anyone who is frequently exposed to the virus through work is eligible for the COVID-19 booster shots six months after receiving their second dose. According to Fauci, it is expected that everyone will eventually need booster sh…

SHARE

by Zak Failla
News
COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says
Covid-19: Immunocompromised People May Need Fourth Dose, CDC Says Some Americans may require a fourth shot of the COVID-19 vaccine if they are immunocompromised, according to new federal guidance. The Centers for Disease Control and Prevention (CDC), said that adults 18 and older who received the Pfizer or Moderna COVID-19 vaccines and are moderately or severely immunocompromised may get a fourth dose at least six months after getting their third shot, the guidance states. Officials cautioned that Johnson & Johnson recipients “should not receive more than two COVID-19 vaccine doses,” though a second is recommended. The CDC authorized a thir…

SHARE

by Zak Failla
News
COVID-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says COVID-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says
Covid-19: Moderna Vaccine Safe, Effective For Children Ages 6 To 11, Company Says Moderna has declared that its two-dose COVID-19 vaccine is safe and has produced a strong antibody response in children between the ages of 6 and 11. A new study of children in that age group found that the vaccine is safe to administer 28 days apart, according to the company and National Institutes of Health, which used shots with a 50 microgram dose of the vaccine, half the dosage for adults. In total, nearly 5,000 children participated in the study, the results of which were announced in a press release, but have yet to be peer-reviewed or published in a journal. The most common side …

SHARE

by Zak Failla
News
COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans
Covid-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans The Food and Drug Administration has authorized the use of Johnson & Johnson and Moderna COVID-19 booster shots for millions of people across the United States. The FDA made the announcement on Wednesday afternoon, Oct. 20, nearly a month after the agency authorized the use of a Pfizer COVID-19 booster shot.  The agency said a single booster dose of the Moderna vaccine can be administered at least six months after the two-dose vaccine series is complete in the following groups of people: 65 years of age and older 18 through 64 years of age at high risk of severe COVID-19 18 …

SHARE

by Nicole Valinote